You and many others but every stock has its twists and turns. At this point the stock is too cheap NOT to buy. The major point of concern was the approval, as that was not a controlled affair. Now that the stock is approved, this is a takeover target. The logic for having it UNNAMED , is that the new owners will exercise that option.
By the way, I respect anyone walking away and taking a profit at any point. Heck, I even respect those who are shorting and profit. Profit is always a good thing. That is why I am staying in - because I am looking to profit. I have bought and sold KERX - even sold my remaining position at $18 before the approval, then bought back in at $16 after the approval. At this point I am ahead of the game but, like you , I am surprised at this low moment we are in now - after being approved.
The catalysts will be rumblings of a buy out and when that eventually occurs. Even the drug being named will be a catalyst. Also , the drug being marketed will be a catalyst.
Thank you for your well wishes.
Let's say you are looking to purchase a vehicle. You know exactly the model and color you like. You even found the exact one that Kevin has down the road. Good thing for you that Kevin is unaware of the rare value of this car that you know is easily worth 25K. To help you out, you call upon an unbiased mechanic who meets you and Kevin to discuss this car's mechanical flaws and value. Little does Kevin, the car's seller know, that you have a pact with the mechanic that is long standing.
After a test drive , the mechanic comes up with some major concerns about the brake lines, the engine mounts, and even a transmission flaw he says is characteristic of this particular vehicle. With all the repair concerns, he declares a value of 15K.
Kevin, the vehicle owner, had originally wanted 20K but after hearing this so-called unbiased mechanic, he is feeling , he'd be lucky to get anything over 15K.
So you offer 15K and Kevin is torn. Of course he comes down to 18K and finally the dust settles at 17K for a car you know is well worth 25K.
As far as KERYX goes . . . . it's a similar deal. The stock price was getting a little high. Merck, Sanofi, GSK, Bristol, or one of these big pharm players wants to buy. Keryx wants to sell. The Keryx boys are getting their cut (they are the mechanics). You (the stockholder) are the seller. The bad label is the flaw. You thought you would get $25 - $30 a share with a buy out but now , you would be happy with $20-$23 even though, with this approval, you know the stock should be higher than the $18 pre-approval trade price.
You can whine all you want that you are not getting $30 a share but you really should be buying at $15.
PFZEIR may have an ERECTION to buy out KERYX. At $16 , the #$%$ must be very stiff.
The buyout by Sanofi is looking very possible. This is an area of expertise Sanofi would like to retain a monopoly on. As far as the label. . . . . they all have a label and some even warn of death.
Reports by the National Federation of Intense Pleasure have determined that the manufactured drug from Keryx Biopharmaceutals brings forth a sudden urge of desire that can last anywhere from 15 to 45 minutes of major pleasure when women who are naked ingest a standard dosage of Zenerex. The NFIP calls is the ENRICHING WONDER DRUG.
Please understand there are side effects that men have had while their woman has been ENRICHED. One had a broken hip and many have experienced a type of rub rash on their private organ. Samuel Erlich says it turned his wife into a raging jack rabbit with the power of 20 energizing bunnies. Dave Funyon declared he had not seen the sliding cave for 6 months and once his wife's meds were updated with an improved kidney function, other functions kicked in with it. Bottom line - dang , this is good stuff.
We have a slow move to $20 due to the coverage on Friday. Heck, $18 is a given for those speculating that this would be approved. Now that hurdle is surpassed, there is every reason for the move to $20 to occur. The drug - no matter what they decide to name it, will be marketed over the next few months with a grand opening bash to hit the market early next quarter.
The other potential is for a buyout - this was not probable until this approval occurred. In fact, the smart money bought yesterday, on the pullback when they saw the approval. The smart money is also buying here and NOW at $17. Every drug has a warning label so that was just a reaction to an opinion yesterday. Now the move is upward and beyond.
Personally, I think every drug company is eyeing this one or better yet, there is already a claim stake on this prize. So - the take away - $18 is yours for the taking , $20 follows shortly for a brief wait, and the bigger prize may be in the winds with a buyout. Don't be stupid, at least take the $18 - $1 a share gift staring you in the face.
He is rapping up on his ISIS report first.
There is a solid base there and it will likely hold there in the San Francisco world will begin to crumble. I suspect the ocean will cover most of San Francisco in the near future as a soul cleansing.
Tanning salons across the USA are scraping to get their hands on bootleg Zenerex due to proprietary properties that works in conjunction with the tanning booths for a quicker tan. Since they can only get the Zenerex from Japan, the cost is 12 times what the proposed USA prescription price will be, The other means for obtaining this tanning wonder is to go to an exclusive tanning salon and request the vita-tan treatment. This high dollar treatment includes vitamin, Zenerex, and booth time.
What the heck is wrong with you people saying an announcement is coming over the Labor Day weekend ? Buncha crock heads ! What were you smoking ?
If postponed again, the stock drops to $14. If rejected , the stock drops to $9. If approved, it goes to $21. The upside win is not too big, as the gamble seems to have already have popped the stock from lower pricing seeing that the odds are strong that this approval is in the bag.
Obviously, you are playing the longshot, contrarian bet. Anything you or I say on here has little bearing on the approval or the stock price. It's just entertainment for the readers, Once this move is over, then a different level of shorts and longs will enter the picture.
I believe you will be on the losing end of this play. You have another week or two to frolic. Then a new game will be on.
Really, shorts are still attempting to bring down KERX ? It must be getting desperate.